Back to company

DR. ZELIG ApS: Financial statements 2020

CVR: 29421323

DR. ZELIG ApS (CVR 29421323) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -120,160 and a net result of DKK -240,956 compared with DKK -5,460,284 the year before. Equity amounted to DKK 12,513,247. The solvency ratio was 100%. The company had 1 employee in the financial year.

Gross Profit
-120,160 kr.
Profit/Loss
-240,956 kr.
Equity
12,513,247 kr.
Total Assets
12,513,556 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--120 t.-241 t.12.5 mio.1
2019-0-5.5 mio.12.9 mio.1
2018--412 t.-651 t.18.4 mio.1
2017--22211 mio.19.2 mio.-
2016--1 t.6.2 mio.8.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is DR. ZELIG ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

DR. ZELIG ApS: The 2019 annual report is outSep 1, 2020

DR. ZELIG ApS has published its annual report for 2019. Gross profit came to DKK 0, and the net result was DKK -5,460,284.

About DR. ZELIG ApS

DR. ZELIG ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Edvard Wulff. The company is owned by Morten Edvard Wulff. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 5,881,022 compared with DKK 7,625,711 the year before. Equity amounted to DKK 55,061,769.